Several brokerages have updated their recommendations and price targets on shares of Ventas (NYSE: VTR) in the last few weeks:
- 11/16/2026 – Ventas had its price target lowered by Mizuho from $104.00 to $101.00. They now have an “outperform” rating on the stock.
- 11/16/2026 – Ventas had its price target raised by Wells Fargo & Company from $96.00 to $102.00. They now have an “overweight” rating on the stock.
- 11/11/2026 – Ventas had its price target raised by UBS Group from $90.00 to $99.00. They now have a “neutral” rating on the stock.
- 11/3/2026 – Ventas was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
- 10/29/2026 – Ventas had its price target lowered by Cantor Fitzgerald from $102.00 to $95.00. They now have an “overweight” rating on the stock.
- 10/19/2026 – Ventas had its “buy (b-)” rating reaffirmed by Weiss Ratings.
- 10/19/2026 – Ventas had its price target lowered by Wells Fargo & Company from $104.00 to $96.00. They now have an “overweight” rating on the stock.
- 10/13/2026 – Ventas had its price target lowered by Barclays from $102.00 to $91.00. They now have an “equal weight” rating on the stock.
- 10/12/2026 – Ventas had its price target lowered by Jefferies Financial Group from $102.00 to $95.00.
- 9/21/2026 – Ventas was given a new $100.00 price target by Evercore. They now have an “outperform” rating on the stock.
Ventas Stock Down 1.6%
NYSE:VTR traded down $1.37 during mid-day trading on Thursday, reaching $86.83. The stock had a trading volume of 2,646,501 shares, compared to its average volume of 3,627,482. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.43 and a quick ratio of 0.43. The company has a market capitalization of $45.92 billion, a price-to-earnings ratio of 163.84, a price-to-earnings-growth ratio of 3.61 and a beta of 0.77. Ventas, Inc. has a 1-year low of $73.82 and a 1-year high of $101.60. The stock’s 50 day simple moving average is $86.31 and its two-hundred day simple moving average is $87.20.
Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.98 by ($0.85). The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. Ventas had a return on equity of 1.86% and a net margin of 3.86%. The company’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.88 EPS. Equities analysts anticipate that Ventas, Inc. will post 3.89 EPS for the current year.
Ventas Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Wednesday, September 30th. Ventas’s dividend payout ratio (DPR) is presently 392.45%.
Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.
Featured Stories
- Five stocks we like better than Ventas
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Ventas Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc and related companies with MarketBeat.com's FREE daily email newsletter.
